Cipla partners with Qilu Pharmaceutical for licensing and supply of biosimilar to Keytruda in US EP News Bureau Sep 7, 2026 Invagen Pharmaceuticals, a wholly owned subsidiary of Cipla announced that it has entered into a strategic partnership with Qilu…
